Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 16421420

Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2006 Jan 20
First author
Kulke MH

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Kulke MH
      type
      Author
    2. name
      Stuart K
      type
      Author
    3. name
      Enzinger PC
      type
      Author
    4. name
      Ryan DP
      type
      Author
    5. name
      Clark JW
      type
      Author
    6. name
      Muzikansky A
      type
      Author
    7. name
      Vincitore M
      type
      Author
    8. name
      Michelini A
      type
      Author
    9. name
      Fuchs CS
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Kulke MH
      type
      Author
    2. name
      Stuart K
      type
      Author
    3. name
      Enzinger PC
      type
      Author
    4. name
      Ryan DP
      type
      Author
    5. name
      Clark JW
      type
      Author
    6. name
      Muzikansky A
      type
      Author
    7. name
      Vincitore M
      type
      Author
    8. name
      Michelini A
      type
      Author
    9. name
      Fuchs CS
      type
      Author
    bibliography ids
    1. nci-bib-60eff41998ad09cf9216d7a1
    book metadata
    content sha256
    7c4179ec6c127fb9dfa57f4867e40cc23ff359de06635cf5e0df6fd568384354
    document type
    citation
    dois
    1. 10.1200/JCO.2005.03.6046
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:16421420
    immutable id
    pubmed:16421420@7c4179ec6c127fb9dfa57f4867e40cc23ff359de06635cf5e0df6fd568384354
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    3
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    401-6
    volume
    24
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      16421420
      provenance
      batch id
      a181c30258a88d182e78
      provider
      NCBI PubMed ESummary
      record sha256
      ff144e4bb6ff99117011fb4d0e5b5e8a7f28b23223cea676556a14620d08150a
      response sha256
      558e0dce453ae424567844b062522ebd1d27363c3312c81dbf6f32a8ff08da24
      retrieved at
      2026-09-09T23:46:03.896343+00:00
      publication date
      display
      2006 Jan 20
      precision
      day
      year
      2006
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Research Support, N.I.H., Extramural
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/16421420/
      title
      Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors.

      Preserved source evidence · Not medical advice